Xconomy’s Digital Events →
I had the pleasure of sitting down with David Hauser recently to talk about his Boston-area company, the Grasshopper Group.
David is the CTO of the company and co-founded it with... Read more »
Sponsored · Whitepaper
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
Sponsored · Webinar
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.